Healthcare -
Biotechnology - NASDAQ - US
$ 12.89
3.04 %
$ 1.09 B
Market Cap
-7.96
P/E
Price Target
Average
74.55%
Revenue Forecast
Estimate
189.94%
EBIT
Estimate
--79.76%
Net Income
Estimate
47.32%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Liquidia Corporation
Wall Street analysts predict an average 1-year price target for LQDA of $22.5 , with forecasts ranging from
a
low of
$17 to a high of $27 .
LQDA Lowest Price Target
Wall Street Target
17 USD
31.89%
LQDA Average Price Target
Wall Street Target
22.5 USD
74.55%
LQDA Highest Price Target
Wall Street Target
27 USD
109.46%
REVENUE FORECAST
Revenue Forecast Chart LQDA
EBIT FORECAST
EBIT Forecast Chart LQDA
NET INCOME FORECAST
Net Income Chart LQDA